AVADEL LEGACY PHARMACEUTICALS, LLC – Trademark Portfolio
Entity Type: 16
AVADEL LEGACY PHARMACEUTICALS, LLC holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include AKOVAZ. The owner is based in CHESTERFIELD, MO.
16640 CHESTERFIELD GROVE ROAD, SUITE 200
CHESTERFIELD, MO 63005
Showing of trademarks Trademarks
Trademark Classifications
AVADEL LEGACY PHARMACEUTICALS, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does AVADEL LEGACY PHARMACEUTICALS, LLC have?
AVADEL LEGACY PHARMACEUTICALS, LLC has 8 U.S. trademarks filed with the USPTO. Of these, 1 registered, 5 abandoned, 2 cancelled.
What trademark classes does AVADEL LEGACY PHARMACEUTICALS, LLC file in?
AVADEL LEGACY PHARMACEUTICALS, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are AVADEL LEGACY PHARMACEUTICALS, LLC's most well-known trademarks?
AVADEL LEGACY PHARMACEUTICALS, LLC's registered trademark portfolio includes well-known marks such as AKOVAZ. These are among 1 currently registered trademark in the portfolio.
What is AVADEL LEGACY PHARMACEUTICALS, LLC's trademark registration success rate?
AVADEL LEGACY PHARMACEUTICALS, LLC has a 13% trademark registration rate, with 1 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.